UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?

Osteoporosis international, 2017-08, Vol.28 (8), p.2465-2473

2017

Volltextzugriff (PDF)

Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years’ experience in a single center

Osteoporosis international, 2017-11, Vol.28 (11), p.3251-3259

2017

Volltextzugriff (PDF)

Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)

Osteoporosis international, 2017-01, Vol.28 (1), p.389-398

2017

Volltextzugriff (PDF)

Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates

Osteoporosis international, 2020, Vol.31 (1), p.181-191

2020

Volltextzugriff (PDF)

Bisphosphonates and their influence on fracture healing: a systematic review

Osteoporosis international, 2015-04, Vol.26 (4), p.1251-1260

2015

Volltextzugriff (PDF)

Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study

Osteoporosis international, 2019-01, Vol.30 (1), p.221-229

2019

Volltextzugriff (PDF)

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

Osteoporosis international, 2009-08, Vol.20 (8), p.1353-1362

2009

Volltextzugriff (PDF)

Osteoporosis in the age of COVID-19

Osteoporosis international, 2020-07, Vol.31 (7), p.1189-1191

2020

Volltextzugriff (PDF)

Addition of dexamethasone to manage acute phase responses following initial zoledronic acid infusion

Osteoporosis international, 2021-04, Vol.32 (4), p.663-670

2021

Volltextzugriff (PDF)

Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure

Osteoporosis international, 2019-12, Vol.30 (12), p.2515-2520

2019

Volltextzugriff (PDF)

The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy

Osteoporosis international, 2012-11, Vol.23 (11), p.2703-2711

2012

Volltextzugriff (PDF)

Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers

Osteoporosis international, 2024-04, Vol.35 (4), p.589-598

2024

Volltextzugriff (PDF)

Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)

Osteoporosis international, 2023-08, Vol.34 (8), p.1369-1379

2023

Volltextzugriff (PDF)

Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur

Osteoporosis international, 2018-02, Vol.29 (2), p.501-506

2018

Volltextzugriff (PDF)

Bisphosphonate holidays: using cost-effectiveness analysis for the “yes, but” questions

Osteoporosis international, 2021-12, Vol.32 (12), p.2389-2390

2021

Volltextzugriff (PDF)

Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy—a long-term radiological follow-up

Osteoporosis international, 2019-12, Vol.30 (12), p.2417-2428

2019

Volltextzugriff (PDF)

Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate

Osteoporosis international, 2014-07, Vol.25 (7), p.1953-1961

2014

Volltextzugriff (PDF)

Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database

Osteoporosis international, 2022-07, Vol.33 (7), p.1579-1589

2022

Volltextzugriff (PDF)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

Osteoporosis international, 2011-02, Vol.22 (2), p.373-390

2011

Volltextzugriff (PDF)

Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study

Osteoporosis international, 2024-04, Vol.35 (4), p.669-678

2024

Volltextzugriff (PDF)

Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance

Osteoporosis international, 2020-12, Vol.31 (12), p.2425-2438

2020

Volltextzugriff (PDF)

The efficacy and safety of bisphosphonate analogs for treatment of osteoporosis after spinal cord injury: a systematic review and meta-analysis of randomized controlled trials

Osteoporosis international, 2021-06, Vol.32 (6), p.1117-1127

2021

Volltextzugriff (PDF)

Upper gastrointestinal safety of oral bisphosphonate in hospitalized patients

Osteoporosis international, 2021, Vol.32 (1), p.193-197

2021

Volltextzugriff (PDF)

Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repair

Osteoporosis international, 2022-04, Vol.33 (4), p.807-820

2022

Volltextzugriff (PDF)

Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study

Osteoporosis international, 2022-06, Vol.33 (6), p.1323-1334

2022

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Zeitschrift / SerieOsteoporosis International

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(151)

Publikationsform

Artikel
(151)

Sprache

Englisch
(151)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(149)
Endocrinology & Metabolism
(148)
Life Sciences & Biomedicine
(148)
Science & Technology
(148)
Endocrinology
(131)
Medicine
(131)
Medicine & Public Health
(131)
Orthopedics
(131)
Rheumatology
(131)
Diphosphonates - Adverse Effects
(118)
Female
(114)
Osteoporosis
(112)
Bone Density Conservation Agents - Adverse Effects
(108)
Middle Aged
(87)
Bisphosphonates
(86)
Aged
(85)
Original Article
(85)
Diphosphonates - Therapeutic Use
(76)
Bone Density Conservation Agents - Therapeutic Use
(67)
Osteoporosis - Drug Therapy
(66)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(151)
MEDLINE
(151)
Journals@Ovid Full Text
(151)
Ingenta
(151)
SpringerLink_现刊
(151)
IngentaConnect Journals
(2)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?

Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years’ experience in a single center

Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)

Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates

Bisphosphonates and their influence on fracture healing: a systematic review

Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

Osteoporosis in the age of COVID-19

Addition of dexamethasone to manage acute phase responses following initial zoledronic acid infusion

Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure

The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy

Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers

Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS)

Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur

Bisphosphonate holidays: using cost-effectiveness analysis for the “yes, but” questions

Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy—a long-term radiological follow-up

Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate

Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study

Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance

The efficacy and safety of bisphosphonate analogs for treatment of osteoporosis after spinal cord injury: a systematic review and meta-analysis of randomized controlled trials

Upper gastrointestinal safety of oral bisphosphonate in hospitalized patients

Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repair

Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study

Aktive Filter

Suchergebnisse filtern